戻る Agenda
Session 1: Keynote Address
Session Chair(s)
Marc Poitras, PHD, MBA
Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau, Health Canada, Canada
There are a myriad of regulatory changes in the works and in the wings, from Patented Medicine pricing reviews, new collaborations with HTA reviewers and other regulators, to review and approval process improvements. While both exciting and at times maybe frightening, these changes should ultimately ease our access to innovative medicines. Hear from a key stakeholder in the telecommunications industry (also heavily regulated) about his experience, lessons learned, and how to keep your focus on the right outcomes.
Speaker(s)
Karen Feltmate
President, Redstone Health Group, Inc., Canada
Panelist
Robert Ghiz
President and CEO, Canadian Wireless Telecommunications Association, Canada
Working Through Regulatory Transformation: Lessons Learned From a Related Industry
Pierre Sabourin, MBA
Assistant Deputy Minister, Health Products and Food Branch, Health Canada, Canada
Panelists: